Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective
Expert Review of Pharmacoeconomics & Outcomes Research · 2023
DOI: 10.1080/14737167.2023.2186400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2023. Verfasst von Farhad Lotfi und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Health Insurance Research, Tehran, Iran. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Cervical cancer is one of the most common cancers in women, the cause of which is mostly human papilloma virus (HPV). The aim of this study was to determine the economic burden of cervical cancer and premalignant lesions associated with HPV infection from a societal perspective. METHODS: The study is a partial economic evaluation (cost of illness), which was conducted cross-sectionally in the referral university clinic in Fars province in 2021. The prevalence-based and bottom-up approaches used to calculate the costs, the indirect costs were calculated by human capital approach. RESULTS: The mean cost of premalignant lesions associated with HPV infection was USD 2,853 per patient, which 68.57% was direct medical costs. In addition, the mean cost of cervical cancer was USD 39,327 per patient, the largest share of which (57.9%) was related to indirect costs. The mean annual cost of cervical cancer patients in the country was estimated at USD 40,884,609 as well. CONCLUSION: Cervical cancer and premalignant lesions associated with HPV infection imposed a significant economic burden on the health system and patients. The results of the present study can help health policymakers with efficient and equitable prioritization and allocation of resources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Center for Health Insurance Research, Tehran, Iran.
- Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
- Student Research Committee, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
- School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
- Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Emergency Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Mehdi Rezaee, Hamed Rahimi, Khosro Keshavarz
Zitieren
APA
Lotfi, F., Khodabandeh, F., Jafari, A., Rezaee, M., Rahimi, H., Shiravani, Z., & Keshavarz, K. (2023). Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2023.2186400
Vancouver
Lotfi F, Khodabandeh F, Jafari A, Rezaee M, Rahimi H, Shiravani Z, et al. Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective. Expert Review of Pharmacoeconomics & Outcomes Research. 2023. doi:10.1080/14737167.2023.2186400
BibTeX
@article{Lotfi2023,
author = {Lotfi, Farhad and Khodabandeh, Fatemeh and Jafari, Abdosaleh and Rezaee, Mehdi and Rahimi, Hamed and Shiravani, Zahra and Keshavarz, Khosro},
title = {Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective},
journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
year = {2023},
doi = {10.1080/14737167.2023.2186400}
}
EUVIMED